Dong Sung Bio Pharm.Co.,Ltd. (KRX: 002210)

Dong Sung Bio Pharm.Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2011	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Cash & Equivalents	8,147	8,147	7,395	2,925	5,241	5,763
Short-Term Investments	774.12	774.12	2,287	4,794	405	-
Trading Asset Securities	5,324	5,324	8,437	5,073	7,942	7,940
Cash & Short-Term Investments	14,246	14,246	18,120	12,791	13,589	13,703
Cash Growth	-33.98%	-21.38%	41.66%	-5.87%	-0.83%	45.40%
Accounts Receivable	45,278	45,278	44,806	47,113	43,998	42,912
Other Receivables	700.07	700.07	420.8	780.64	477.53	1,557
Receivables	48,171	48,171	46,329	48,836	44,828	44,569
Inventory	11,176	11,176	10,554	12,082	10,325	10,173
Prepaid Expenses	77.35	77.35	225.03	161.69	203.19	97.72
Other Current Assets	1,378	1,378	1,720	1,962	3,623	1,651
Total Current Assets	75,048	75,048	76,947	76,206	72,622	70,740
Property, Plant & Equipment	30,617	30,617	27,666	47,700	48,248	28,254
Long-Term Investments	1,160	1,160	1,366	2,152	1,869	1,983
Other Intangible Assets	1,166	1,166	967.72	812.2	758.39	168.32
Long-Term Deferred Tax Assets	-	-	-	-	-	1,024
Other Long-Term Assets	16,410	16,410	20,661	836.48	1,073	1,249
Total Assets	124,577	124,577	127,808	127,906	124,570	103,417
Accounts Payable	12,398	12,398	12,162	9,421	9,676	9,544
Accrued Expenses	1,976	1,976	2,488	1,778	2,009	1,322
Short-Term Debt	32,168	32,168	30,046	23,300	19,700	23,400
Current Portion of Long-Term Debt	1,127	1,127	869	6,247	337.74	925.24
Current Income Taxes Payable	266.34	266.34	4,073	-	345.84	1,101
Current Unearned Revenue	51.06	51.06	191.99	-	-	-
Other Current Liabilities	2,934	2,934	3,156	3,000	3,951	2,789
Total Current Liabilities	50,920	50,920	52,986	43,746	36,020	39,080
Long-Term Debt	1,636	1,636	2,763	1,758	6,999	7,056
Long-Term Deferred Tax Liabilities	2,708	2,708	3,019	4,403	4,331	-
Other Long-Term Liabilities	7,385	7,385	7,788	7,176	7,116	7,377
Total Liabilities	64,376	64,376	68,706	59,936	56,747	57,278
Common Stock	21,128	21,128	21,128	21,128	21,128	21,128
Additional Paid-In Capital	11,261	11,261	11,261	11,528	11,528	11,528
Retained Earnings	31,913	31,913	30,814	19,250	19,227	16,115
Treasury Stock	-4,101	-4,101	-4,101	-3,201	-3,201	-3,201
Comprensive Income & Other	-	-	-	19,265	19,142	569.62
Shareholders' Equity	60,201	60,201	59,102	67,970	67,823	46,139
Total Liabilities & Equity	124,577	124,577	127,808	127,906	124,570	103,417
Total Debt	34,930	34,930	33,677	31,305	27,037	31,381
Net Cash (Debt)	-20,685	-20,685	-15,557	-18,514	-13,448	-17,678
Net Cash Per Share	-1171.40	-1171.40	-863.57	-1019.60	-740.63	-1016.30
Filing Date Shares Outstanding	17.66	17.66	17.66	18.16	18.16	18.16
Total Common Shares Outstanding	17.66	17.66	17.66	18.16	18.16	18.16
Working Capital	24,128	24,128	23,961	32,459	36,602	31,659
Book Value Per Share	3409.29	3409.29	3347.02	3743.24	3735.15	2540.97
Tangible Book Value	59,035	59,035	58,134	67,158	67,064	45,971
Tangible Book Value Per Share	3343.24	3343.24	3292.22	3698.51	3693.38	2531.70
Land	16,494	16,494	13,374	30,235	30,230	8,992
Buildings	21,217	21,217	20,018	25,118	25,060	25,506
Machinery	8,844	8,844	8,460	8,911	8,711	8,294
Construction In Progress	-	-	95.37	19.32	-	89.18

Source: S&P Capital IQ. Standard template. Financial Sources.